Client Profile

SDG, Inc.

SDG, Inc. was formed in 1993 to develop its proprietary nanotechnology-based drug and diagnostics delivery systems. SDG has spun-out several therapeutic specific companies, including Diasome Pharmaceuticals, Inc. a venture-backed company focused on hepatic specific oral and injectable insulin therapies. SW's technology pipeline includes active programs in oral protein delivery, diabetes, metabolic/obesity, cancer diagnostics, and hepatitis. For more information, please email Bob Geho at

Vice President
Robert Geho
Type of Business
Number of Employees